Many tests are ongoing to validate its effect in previously stages of GC[60] even now. Anti-VEGF mABs (Bevacizumab): Bevacizumab continues to be evaluated for advanced
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
Many tests are ongoing to validate its effect in previously stages of GC[60] even now. Anti-VEGF mABs (Bevacizumab): Bevacizumab continues to be evaluated for advanced